Benzoate X Receptors α and β Are Pharmacologically Distinct and Do Not Function as Xenobiotic Receptors
Authors:
- Ranga N. VenkatesanRVRanga N. Venkatesan
- Michelle M. TabbMTMichelle M. Tabb
- Changcheng ZhouCZChangcheng Zhou
- Junran CaoJCJunran Cao
- Daniel HemmatiDHDaniel Hemmati
- Bruce BlumbergBBBruce Blumberg
Open Access
- 1 November 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (46) , 43691-43697
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Nuclear Receptors and Lipid Physiology: Opening the X-FilesScience, 2001
- Peptide Mimetic HIV Protease Inhibitors Are Ligands for the Orphan Receptor SXRJournal of Biological Chemistry, 2001
- Molecular Cloning and Functional Characterization of a Novel Nuclear Receptor Similar to an Embryonic Benzoate Receptor BXRBiochemical and Biophysical Research Communications, 2000
- SXR, a novel steroid and xenobioticsensing nuclear receptorGenes & Development, 1998
- The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.Journal of Clinical Investigation, 1998
- BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolitesGenes & Development, 1998
- Anhydroretinol: a naturally occurring inhibitor of lymphocyte physiology.Journal of Experimental Medicine, 1993
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973